Rising Star: Skadden's Chadé Severin
Law360 (July 2, 2021, 3:02 PM EDT) -- Chadé Severin of Skadden Arps Slate Meagher & Flom LLP drove complex deals in the biopharma sector, including Gilead's $4.9 billion acquisition of cancer immunotherapy firm Forty Seven Inc., landing her...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login